Richard D. Francis, President and CEO: Teva Pharmaceutical Industries TEVA Planned sale · Filed 02/18

Trade details

Type: Planned sale notice
Stock: Teva Pharmaceutical Industries TEVA
Person: Richard D. FrancisPresident and CEO
Planned sale date: 26/02/17
Filed: 26/02/18

2.9% of shares outstanding to be sold

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Richard D. Francis's recent trades

Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/08
Traded 06/05
Richard D. FrancisPresident and CEO
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/05
Traded 06/05
Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/09
Traded 03/05
Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$759.3K
23,393 sh
$759.3K
Filed 03/06
Traded 03/04
Richard D. FrancisPresident and CEO
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/05
Traded 03/05